Lemaitre Vascular Inc (LMAT)

Why You Should Add Encompass Health (EHC) to Your Portfolio Now

Zacks Investment Research

LeMaitre Vascular (LMAT) Q1 Earnings Preview: What's in the Cards? - Yahoo Movies UK

Yahoo Movies UK

Summit Creek Advisors LLC Boosts Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Reaches New 12-Month High at $76.26 - MarketBeat

MarketBeat

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Declares Quarterly Dividend of $0.16 - MarketBeat

MarketBeat

LeMaitre Vascular First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Simply Wall St

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

MarketBeat

Trend Tracker for (LMAT) - Stock Traders Daily

Stock Traders Daily

Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think " Yes " - Yahoo News UK

Yahoo News UK

Mesirow Institutional Investment Management Inc. Invests $8.84 Million in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

MarketBeat

StockNews.com Downgrades LeMaitre Vascular (NASDAQ:LMAT) to Hold - MarketBeat

MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Lowered to “Hold” at StockNews.com - Defense World

Defense World

Why You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming Dividend - Yahoo Finance

Yahoo Finance

Have LeMaitre Vascular Insiders Been Selling Stock? - Simply Wall St

Simply Wall St

Los Angeles Capital Management LLC Cuts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World

Defense World

Insider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 8000 Shares of Stock - Defense World

Defense World

Insider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 68906 Shares of Stock - Defense World

Defense World

Insider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells 5,025 Shares of Stock - MarketBeat

MarketBeat

LeMaitre Vascular CEO sells shares worth over $9.3 million - Investing.com India

Investing.com India

LeMaitre Vascular president sells over $379k in company stock - Investing.com

Investing.com

LeMaitre Vascular president sells over $379k in company stock By Investing.com - Investing.com Canada

Investing.com Canada

LeMaitre Vascular CEO sells shares worth over $9.3 million - Investing.com South Africa

Investing.com South Africa

Insider Sale: President and Director David Roberts Sells Shares of LeMaitre Vascular Inc (LMAT) - Yahoo Finance

Yahoo Finance

LeMaitre Vascular CEO sells shares worth over $9.3 million - Investing.com Australia

Investing.com Australia

LeMaitre Vascular CEO sells shares worth over $9.3 million - Investing.com Canada

Investing.com Canada

LeMaitre Vascular CEO sells shares worth over $9.3 million - Investing.com

Investing.com

LeMaitre Vascular (NASDAQ:LMAT) jumps 5.4% this week, though earnings growth is still tracking behind three-year ... - Yahoo News UK

Yahoo News UK

Insider Sale: President and Director David Roberts Sells Shares of LeMaitre Vascular Inc (LMAT) - Yahoo Finance

Yahoo Finance

LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $79.00 at Barrington Research - Defense World

Defense World

LeMaitre Vascular (NASDAQ:LMAT) Upgraded to “Buy” by StockNews.com - Defense World

Defense World

Bioprosthetics Industry Research Study |LeMaitre Vascular, Inc., Braile Biomedica - Motions Online

Motions Online

LeMaitre Vascular (LMAT) Lags Q3 Earnings and Revenue Estimates - Yahoo News UK

Yahoo News UK

LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance

Yahoo Finance

LeMaitre Vascular First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Yahoo Finance

Earnings call: LeMaitre Vascular sees robust growth in Q1 2024 - Investing.com India

Investing.com India

LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Up on Earnings Beat - MarketBeat

MarketBeat

LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates - MSN

MSN

LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates - Zacks Investment Research

Zacks Investment Research

LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates

Zacks Investment Research

When the Price of (LMAT) Talks, People Listen - Stock Traders Daily

Stock Traders Daily

LeMaitre Q1 2024 Financial Results - GlobeNewswire

GlobeNewswire

LeMaitre Q1 2024 Financial Results

GlobeNewswire Inc.

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear - Simply Wall St

Simply Wall St

LeMaitre Vascular (NASDAQ:LMAT) Lifted to “Buy” at Stifel Nicolaus - Defense World

Defense World

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024

GlobeNewswire Inc.

AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management

Zacks Investment Research

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 - Yahoo Finance

Yahoo Finance

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Zacks Investment Research

Here's Why You Should Hold BD (BDX) Stock in Your Portfolio

Zacks Investment Research

Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio

Zacks Investment Research